Interfering with influenza: nonlinear coupling of reactive and static mitigation strategies.


Journal

Journal of the Royal Society, Interface
ISSN: 1742-5662
Titre abrégé: J R Soc Interface
Pays: England
ID NLM: 101217269

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 23 4 2020
pubmed: 23 4 2020
medline: 22 6 2021
Statut: ppublish

Résumé

When new, highly infectious strains of influenza emerge, global pandemics can occur before an effective vaccine is developed. Without a strain-specific vaccine, pandemics can only be mitigated by employing combinations of low-efficacy pre-pandemic vaccines and reactive response measures that are carried out as the pandemic unfolds. Unfortunately, the application of reactive interventions can lead to unintended consequences that may exacerbate unpredictable spreading dynamics and cause more drawn-out epidemics. Here, we employ a detailed model of pandemic influenza in Australia to simulate the combination of pre-pandemic vaccination and reactive antiviral prophylaxis. This study focuses on population-level coupling effects between the respective methods, and the associated spatio-temporal fluctuations in pandemic dynamics produced by reactive strategies. Our results show that combining strategies can produce either mutual improvement of performance or interference that reduces the effectiveness of each strategy when they are used together. We demonstrate that these coupling effects between intervention strategies are extremely sensitive to delay times, compliance rates and the type of contact targeting used to administer prophylaxis.

Identifiants

pubmed: 32316882
doi: 10.1098/rsif.2019.0728
pmc: PMC7211476
doi:

Substances chimiques

Antiviral Agents 0
Influenza Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20190728

Références

Clin Infect Dis. 2011 Apr 1;52(7):911-6
pubmed: 21427399
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Jul;66(1 Pt 2):016128
pubmed: 12241447
Interface Focus. 2018 Dec 6;8(6):20180036
pubmed: 30443333
Lancet. 2010 Mar 27;375(9720):1100-8
pubmed: 20096450
Am J Epidemiol. 2004 Apr 1;159(7):623-33
pubmed: 15033640
PLoS One. 2011 Feb 04;6(2):e14505
pubmed: 21346794
Euro Surveill. 2010 Dec 09;15(49):
pubmed: 21163178
Entropy (Basel). 2020 Jan 22;22(2):
pubmed: 33285908
BMC Infect Dis. 2010 Jun 29;10:190
pubmed: 20587041
Aust N Z J Public Health. 2010 Apr;34(2):113-9
pubmed: 23331352
PLoS Comput Biol. 2011 Feb 10;7(2):e1001076
pubmed: 21347316
Theor Ecol. 2013;6(3):333-357
pubmed: 32218877
PLoS One. 2013 Apr 09;8(4):e61504
pubmed: 23585906
Science. 2006 Apr 21;312(5772):447-51
pubmed: 16574822
J R Soc Interface. 2009 Dec 6;6(41):1121-34
pubmed: 19324673
Sci Adv. 2018 Dec 12;4(12):eaau5294
pubmed: 30547086
J Public Health (Oxf). 2014 Mar;36(1):5-12
pubmed: 23735960
Math Biosci. 2007 Oct;209(2):336-60
pubmed: 17416393
Lancet. 2006 Sep 2;368(9538):886-9
pubmed: 16950366
Proc Biol Sci. 2003 Dec 22;270(1533):2565-71
pubmed: 14728778
Int J Environ Res Public Health. 2019 Jul 11;16(14):
pubmed: 31336761
Theor Biol Med Model. 2014 Jan 13;11:3
pubmed: 24418011
J R Soc Interface. 2010 Jun 6;7(47):873-85
pubmed: 19892718
Lancet Infect Dis. 2008 Oct;8(10):650-8
pubmed: 18922487
PLoS Med. 2009 Dec;6(12):e1000207
pubmed: 19997612
J Infect Dis. 2006 Nov 1;194 Suppl 2:S73-6
pubmed: 17163392
BMC Public Health. 2007 Aug 15;7:208
pubmed: 17697389
Phys Rev Lett. 2003 Dec 12;91(24):247901
pubmed: 14683159
BMC Public Health. 2011 Feb 25;11 Suppl 1:S1
pubmed: 21356128
BMC Infect Dis. 2016 Oct 10;16(1):552
pubmed: 27724915
Science. 2005 Aug 12;309(5737):1083-7
pubmed: 16079251
J Comput Sci. 2010 Aug 1;1(3):132-145
pubmed: 21415939
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5935-40
pubmed: 16585506
Nature. 2005 Sep 8;437(7056):209-14
pubmed: 16079797
Nat Phys. 2011 Jul 1;7:581-586
pubmed: 21799702
Emerg Infect Dis. 2006 Nov;12(11):1671-81
pubmed: 17283616
CMAJ. 2009 Nov 10;181(10):673-80
pubmed: 19825923
PLoS One. 2013;8(1):e53095
pubmed: 23349699
Proc Biol Sci. 2003 Jun 7;270(1520):1129-36
pubmed: 12816650
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12680-12685
pubmed: 30463945
J R Soc Interface. 2013 Feb 06;10(81):20121019
pubmed: 23389899

Auteurs

Cameron Zachreson (C)

Complex Systems Research Group, Faculty of Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia.

Kristopher M Fair (KM)

Complex Systems Research Group, Faculty of Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia.

Nathan Harding (N)

Complex Systems Research Group, Faculty of Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia.

Mikhail Prokopenko (M)

Complex Systems Research Group, Faculty of Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia.
Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Westmead, New South Wales 2145, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH